CTRI/2020/09/027881已完成不适用
An observational multi-center study on COVID 19 disease to study on HERD immunity in the population based on random sampling through conducting at two time points to infer epidemic trajectory.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Compared to the other infections, COVID infections are more asymptomatic and there is a chance to recover without any medications or standard of care for COVID-19 disease.
研究概览
简要总结
COVID-19 is now spreading throughout the world becauseof its high infectivity and communicability. Also there is a lack in the propermanagement of the disease. So any contribution in the knowledge or treatment ofCOVID-19 from any source could be of great value to the medical profession.Thus the present study is proposed to understand the immunity developed by theown and fight against the COVID 19 virus in patients infected with COVID-19infection.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 10.00 Year(s) 至 99.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Apparently Healthy subjects will be recruited.
- •2.Subjects of both sexes aged more than 10 years old.
- •3.Willing and able to provide written informed consent 4.Subjects who has not tested positive for COVID 19 infection in the past.
排除标准
- •1.Subjects having less than 10 years of age 2.Subjects already tested positive for the COVID19 infection in the past and cured.
- •3.Critical co-morbidities.
结局指标
主要结局
Compared to the other infections, COVID infections are more asymptomatic and there is a chance to recover without any medications or standard of care for COVID-19 disease.
时间窗: 14 days
次要结局
- There will be a chance to develop the antibodies or develop the resistance against the COVID-19 can be known as HERD immunity.(There will be reduction in spreading of the COVID infection through developing the immunity and wearing masks and taking all the precautions as per the WHO guidelines.)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
4 期
A clinical trial to study the efficacy and safety of Ayurveda therapy protocol in the management of Covid-19 and its Post complicationsCTRI/2021/07/034937Pankajakasthuri herbal research foundation30
已完成
2 期
Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19)SARS-CoV-2NCT04608214Assistance Publique - Hôpitaux de Paris26
已完成
2 期
Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 CohortCovid19NCT04345991Assistance Publique - Hôpitaux de Paris120
Unknown
不适用
Cytokine Storm Among Bangladeshi Patients With COVID-19Cytokine Storm, COVID-19NCT04598334International Centre for Diarrhoeal Disease Research, Bangladesh75
已完成
不适用
Impact of Covid-19 Pandemic on Management of Head and Neck CancersHead and Neck CancerCovid19Patient CareNCT04704466Centre Hospitalier Universitaire, Amiens44
